For 17 years, Ken Jones fought fires in San Francisco. Now, he is fighting cancer -- and the insurance company that insures ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
The FDA approved ensartinib for the treatment of certain patients with ALK-positive locally advanced or metastatic non-small cell lung cancer. The indication applies to use of the agent for adults not ...
Lung cancer is one of the kinds of cancer that is most likely to spread to the brain. Approximately 20 percent of lung cancer patients develop brain metastases. And roughly 10 to 20 percent of people ...
Chinese pharma Hansoh Pharma (HKEX: 3692) has secured approval from China’s National Medical Products Administration for an ...